Détails du rapport Vaer
Région : Outside US
- Patient décédé?
- Renseignements sur les vaccins
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
- Date de réception du rapport
- Date à laquelle le formulaire est complèté
- Date de vaccination
- Date d’apparition
- Nombre de jours (date d’apparition – date de vaccination)
- Description de l’événement indésirable
swelling of feet/ swelling feet, heels; off label use; interchange of vaccine products; bruisings on feet; this is a spontaneous report received from a contactable reporter (consumer) from the regulatory agency. regulatory number: gb-mhra-webcovid-202202182202452610-qzlxh. other case identifier: gb-mhra-adr 26624086. a 43-year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 13feb2022 (lot number: fk9706) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "rheumatoid arthritis" (unspecified if ongoing). date of last menstrual period: 07feb2022. concomitant medication included: sulphasalazine taken for rheumatoid arthritis, start date: 01jun2019. she was taking a regular medicine for rheumatoid arthritis (or other types of arthritis except osteoarthritis). vaccination history included: covid-19 vaccine astrazeneca (as dose 1, single), administration date: 21mar2021, for covid-19 immunisation and covid-19 vaccine astrazeneca (as dose 2, single), administration date: 16may2021, for covid-19 immunisation. the following information was reported: off label use (medically significant) with onset 13feb2022, outcome "unknown", described as "off label use"; interchange of vaccine products (medically significant) with onset 13feb2022, outcome "unknown", described as "interchange of vaccine products"; peripheral swelling (medically significant) with onset 15feb2022, outcome "not recovered", described as "swelling of feet/ swelling feet, heels"; and contusion (medically significant) with onset feb2022, outcome "unknown", described as "bruisings on feet." the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (12feb2022) negative, notes: no - negative covid-19 test. clinical course: patient has not had symptoms associated with covid-19. she is not pregnant and is not currently breastfeeding. she has not tested positive for covid-19 since having the vaccine and is not enrolled in a clinical trial. no follow-up attempts are possible. no further information is expected
- Données de laboratoire
test date: 20220212; test name: covid-19 virus test; test result: negative ; comments: no - negative covid-19 test
- Liste des symptômes
contusion interchange of vaccine products sars-cov-2 test peripheral swelling off label use
- Patient décédé?
- Date de décès
- Anomalie congénitale
- Vaccin administré par :
- Vaccin acheté par :
- Visite d’un patient à l’urgence?
- Patient hospitalisé?
- Séjour à l’hôpital
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Maladie actuelle